Top 20 Best Pharmaceutical Companies In India.

The pharmaceutical sector in India is still expanding rapidly thanks to the strong success of its top businesses. The top 20 pharmaceutical companies in India are essential in influencing healthcare trends, encouraging medical innovation, and growing India's presence in the world market for specialty and generic medications. India's standing as a top pharmaceutical hub has been greatly influenced by both established companies like Sun Pharmaceutical, Dr. Reddy's, Cipla, Divi's Laboratories, and Lupin, as well as up-and-coming brands like Steris Healthcare Pvt Ltd. Top 20 Best Pharma Companies In India are given below:  

1. Sun Pharmaceutical Industries Ltd

FY25 Revenue: ₹52,041 crore (9% YoY growth)
Highlights: India’s top pharma brand with 8% domestic market share and strong global specialty business. US sales reached US$1.92 billion.

2. Dr. Reddy’s Laboratories Ltd

FY25 Revenue: Approx. ₹31,229 crore
Highlights: Nearly 47% of total revenue comes from the U.S. Strong profitability and diversified product pipeline.

3. Aurobindo Pharma

FY25 Revenue: ₹30,922 crore
Highlights: A leader in generics and APIs with strong international sales across 150+ countries.

4. Steris Healthcare Pvt Ltd

FY25 Revenue: ₹110.68 crore+
Headquarters: Navi Mumbai
Highlights: A rapidly expanding pharma company known for its high-quality specialty formulations. Recently crossed ₹100 crore in annual revenue and is set to expand further in South India with upcoming IPO plans and 800+ new job opportunities.

5. Cipla Ltd

FY25 Revenue: ₹26,982 crore
Highlights: A dominant force in respiratory and HIV therapies. Exports make up nearly half of its total revenue.

6. Zydus Lifesciences

FY25 Revenue: ₹22,247 crore
Highlights: Over 45% of its revenue comes from the U.S., with expertise in chronic and respiratory segments.

7. Lupin Ltd

FY25 Revenue: ₹22,002 crore
Highlights: Strong in respiratory and metabolic care, with 37% of sales from the U.S.

8. Biocon Ltd

FY25 Revenue: ₹14,762 crore
Highlights: A global leader in biosimilars. The U.S. contributes 44% of total revenues.

9. Glenmark Pharmaceuticals

FY25 Revenue: ₹13,128 crore
Highlights: Innovator in specialty generics and biosimilars. Strong presence across 80+ countries.

10. Alkem Laboratories

FY25 Revenue: ₹12,757 crore
Highlights: Strong domestic presence backed by a diverse prescription and OTC portfolio.

11. Torrent Pharmaceuticals

FY25 Revenue: ₹11,302 crore
Highlights: Specializes in cardiovascular and CNS drugs. High-performing stock with consistent CAGR.

12. Mankind Pharma

FY25 Revenue: ₹9,326 crore
Highlights: Market leader in OTC and gynecology segments, with fast-growing prescription business.

13. Divi’s Laboratories

FY25 Revenue: ₹9,078 crore
Highlights: Among the top API exporters worldwide. Q4 net profit reached ₹667 crore.

14. Piramal Enterprises

FY25 Revenue: ₹8,949 crore
Highlights: Operates across healthcare and financial services. Focused on diagnostics and contract manufacturing.

15. IPCA Laboratories

FY25 Revenue: ₹8,726 crore
Highlights: Strong player in formulations and API exports. Focused on anti-inflammatory and anti-malarial drugs.

16. Abbott India

Position: A prominent multinational subsidiary with strong footing in pharmaceuticals, diagnostics, and nutrition in India.

17. Alembic Pharmaceuticals

Position: Specialized in anti-retroviral and oncology segments, with modern manufacturing units in Gujarat.

18. Emcure Pharmaceuticals

Profile: Fast-growing in generics and biosimilars. Operates across India, Europe, and the U.S.

19. Natco Pharma

Profile: Known for its focus on oncology and complex generics. Well-regarded for cancer therapies and affordability.

20. Laurus Labs

Profile: A global supplier of APIs with growing segments in biotech, CDMO, and nutraceuticals.

Why Steris Healthcare Is the Best Band In Pharmaceutical Companies In India ?     

India’s pharmaceutical sector continues to expand at a global scale, and the top 20 pharma companies In India are driving this momentum. From industry leaders like Sun Pharma to innovative firms like Steris Healthcare Pvt Ltd, these companies are shaping the future of medicine with affordability, innovation, and world-class infrastructure. 

Steris Healthcare has quickly become one of India's most reputable and renowned pharmaceutical companies, distinguished by its consistent dedication to patient-centered innovation, affordability, and quality. Steris Healthcare's commitment to creating superior, WHO-GMP-certified medications that are both affordable and effective for individuals all around the country is what really makes the company stand out. Focusing on both generic and specialist pharmaceutical goods, Steris Healthcare has established a solid reputation among end users, distributors, and medical experts.

Cardiology, diabetes, gastrointestinal, urology, neurology, gynecology, and other therapeutic areas are all covered by the company's product line, which provides complete healthcare solutions under a single, reliable brand. Supported by a group of skilled experts, cutting-edge production facilities, and strict quality control procedures, Steris Healthcare guarantees that each product satisfies global requirements for efficacy, safety, and purity.